Steigerwald, Gordon & Koch Inc. Moderna, Inc. Transaction History
Steigerwald, Gordon & Koch Inc.
- $977 Million
- Q3 2025
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 150 shares of MRNA stock, worth $3,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$3,999% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$681 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$589 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$460 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$237 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...